Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
about
Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes.Osteoporosis and autophagy: What is the relationship?Autophagy controls mesenchymal stem cell properties and senescence during bone aging.Rapamycin promotes osteogenesis under inflammatory conditions.Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?Mammalian target of rapamycin as a therapeutic target in osteoporosis.
P2860
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@en
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@nl
type
label
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@en
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@nl
prefLabel
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@en
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@nl
P2093
P2860
P1476
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-015-3325-5
P407
P577
2015-09-22T00:00:00Z